…
World
Centanafadine Approved for ADHD in the United States, Unavailable in France
Herz — World Desk · · 30s summary · 1 min read
The essentials
The United States has approved centanafadine, a new medication to treat attention-deficit/hyperactivity disorder (ADHD), according to Le Monde. The treatment features a mechanism of action described as innovative. It is not available in France. French specialists are warning about the limited number of medications available in the country to treat ADHD.
- Centanafadine, a new ADHD medication, has been approved in the United States.
- Its mechanism of action is described as innovative.
- The medication is not available in France.
- French specialists are warning about the limited number of ADHD treatments available in France.
What We Know
The United States has approved centanafadine, a new medication for treating attention-deficit/hyperactivity disorder (ADHD), according to Le Monde.
This medication features a mechanism of action described as innovative.
Centanafadine is not available in France. French specialists are warning about the limited number of medications available in the country to treat ADHD.
What is centanafadine?
Centanafadine is a new medication approved in the United States to treat ADHD (attention-deficit/hyperactivity disorder). Its mechanism of action is described as innovative.
Is centanafadine available in France?
No, centanafadine is not available in France at this time.
What are French specialists saying about ADHD treatments?
French specialists are warning about the limited number of medications available in France to treat ADHD.
Topics
Related articles
Latest articles
The illustrations in this article are generated by artificial intelligence.
Comments
No comments yet. Be the first to react.
